Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation

Cancer Letters

Volumn 310, Issue 1, 2011, Pages 61-68

  Park, Sun Hye ^a   Lim, Joo Song ^a   Lim, Su Yeon ^a   Tiwari, Indira ^a   Jang, Kyung Lib ^a  

^a Pusan National University   (South Korea)

Author keywords

Core; DNA methylation; Hepatitis C virus; Hepatocellular carcinoma; P16

Indexed keywords

CORE PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; PROTEIN P16; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; G1 PHASE; HEP G2 CELLS; HEPATOBLASTOMA; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; S PHASE; TRANSFECTION; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 79961129427     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.012     Document Type: Article

References (38)

1. Caselmann W.H., Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J. Hepatol. 1996, 24:61-66.
2. Major M.E., Rehermann B., Feinstone S.M. Hepatitis C viruses. Fields Virology 2001, 1127-1161. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
3. Kato N., Yoshida H., Ono-Nita S.K., Kato J., Goto T., Otsuka M., Lan K., Matsushima K., Shiratori Y., Omata M. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000, 32:405-412.
4. Ray R.B., Lagging L.M., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 1996, 70:4438-4443.
5. Basu A., Meyer K., Lai K.K., Saito K., Di Bisceglie A.M., Grosso L.E., Ray R.B., Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 2006, 349:347-358.
6. Severi T., Vander Borght S., Libbrecht L., VanAelst L., Nevens F., Roskams T., Cassiman D., Fevery J., Verslype C., van Pelt J.F. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Chem. Biol. Interact. 2007, 168:128-134.
7. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4:1065-1067.
8. Sherr C.J. Cell cycle control and cancer. Harvey Lect. 2000, 96:73-92.
9. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
10. Azechi H., Nishida N., Fukuda Y., Nishimura T., Minata M., Katsuma H., Kuno M., Ito T., Komeda T., Kita R., Takahashi R., Nakao K. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 2001, 60:346-354.
11. Masaki T., Shiratori Y., Rengifo W., Igarashi K., Yamagata M., Kurokohchi K., Uchida N., Miyauchi Y., Yoshiji H., Watanabe S., Omata M., Kuriyama S. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003, 37:534-543.
12. Bassiouny A.E., Nosseir M.M., Zoheiry M.K., Ameen N.A., Abdel-Hadi A.M., Ibrahim I.M., Zada S., El-Deen A.H., El-Bassiouni N.E. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World J. Hepatol. 2010, 2:32-41.
13. Tsutsumi T., Suzuki T., Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Matsuura Y., Kimura S., Koike K., Miyamura T. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 2002, 304:415-424.
14. Liew C.T., Li H.M., Lo K.W., Leow C.K., Chan J.Y., Hin L.Y., Lau W.Y., Lai P.B., Lim B.K., Huang J., Leung W.T., Wu S., Lee J.C. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 1999, 18:789-795.
15. Zhang C., Li Z., Cheng Y., Jia F., Li R., Wu M., Li K., Wei L. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Clin. Cancer Res. 2007, 13:944-952.
16. Huang J.Z., Xia S.S., Ye Q.F., Jiang H.Y., Chen Z.H. Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells. World J. Gastroenterol. 2003, 9:84-88.
17. Arora P., Kim E.O., Jung J.K., Jang K.L. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett. 2008, 261:244-252.
18. Jung J.K., Arora P., Pagano J.S., Jang K.L. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007, 67:5771-5778.
19. Kim M., Shin D., Kim S.I., Park M. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res. 2006, 122:1-10.
20. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 1996, 93:9821-9826.
21. Kim Y.J., Jung J.K., Lee S.Y., Jang K.L. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation. Cancer Lett. 2010, 288:226-235.
22. Liu Y., Lee M.O., Wang H.G., Li Y., Hashimoto Y., Klaus M., Reed J.C., Zhang X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 1996, 16:1138-1149.
23. Fukutomi T., Zhou Y., Kawai S., Eguchi H., Wands J.R., Li J. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology 2005, 41:1096-1105.
24. Sato Y., Kato J., Takimoto R., Takada K., Kawano Y., Miyanishi K., Kobune M., Takayama T., Matunaga T., Niitsu Y. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 2006, 55:1801-1808.
25. Erhardt A., Hassan M., Heintges T., Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002, 292:272-284.
26. Bigey P., Ramchandani S., Theberge J., Araujo F.D., Szyf M. Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene 2000, 242:407-418.
27. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 2001, 98:13681-13686.
28. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001, 61:4365-4370.
29. Tsutsumi T., Suzuki T., Shimoike T., Suzuki R., Moriya K., Shintani Y., Fujie H., Matsuura Y., Koike K., Miyamura T. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 2002, 35:937-946.
30. Li X., Hui A.M., Sun L., Hasegawa K., Torzilli G., Minagawa M., Takayama T., Makuuchi M. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin. Cancer Res. 2004, 10:7484-7489.
31. Tsai C.L., Li H.P., Lu Y.J., Hsueh C., Liang Y., Chen C.L., Tsao S.W., Tse K.P., Yu J.S., Chang Y.S. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 2006, 66:11668-11676.
32. Kwun H.J., Jang K.L. Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene. J. Viral. Hepat. 2003, 10:249-255.
33. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
34. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
35. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 1999, 18:1571-1583.
36. Liu Y., Yeh N., Zhu X.H., Leversha M., Cordon-Cardo C., Ghossein R., Singh B., Holland E., Koff A. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). EMBO J. 2007, 26:4683-4693.
37. Jin M., Piao Z., Kim N.G., Park C., Shin E.C., Park J.H., Jung H.J., Kim C.G., Kim H. P16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000, 89:60-68.
38. Kristensen L.S., Nielsen H.M., Hansen L.L. Epigenetics and cancer treatment. Eur. J. Pharmacol. 2009, 625:131-142.